Quarterly report pursuant to Section 13 or 15(d)

Research and Development Agreements - Schedule of Condensed Consolidated Balance Sheet (Detail)

v3.8.0.1
Research and Development Agreements - Schedule of Condensed Consolidated Balance Sheet (Detail) - USD ($)
$ in Thousands
Mar. 31, 2018
Jan. 01, 2018
Dec. 31, 2017
ASSETS      
Other current assets $ 144   $ 19
Total assets 87,215   90,391
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Accumulated deficit (73,130)   (64,471)
Total liabilities and stockholder's equity $ 87,215   $ 90,391
ASC 2014-09      
ASSETS      
Other current assets   $ 73  
Total assets   90,445  
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Accumulated deficit   (64,417)  
Total liabilities and stockholder's equity   90,445  
Effect of Adoption of ASC 606 | ASC 2014-09      
ASSETS      
Other current assets   54  
Total assets   54  
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Accumulated deficit   54  
Total liabilities and stockholder's equity   $ 54